Abstract
An efficient, mild, cost effective and eco-friendly synthesis of 2,3- dihydroquinazoline- 4(1H)-ones is described in which isatoic anhydride, primary amines and variety of aldehydes react in the presence of citric acid as a green, bioorganic and inexpensive catalyst via rapid one-pot threecomponent reaction in boiling ethanol.
Keywords: Aldehydes, bioorganic catalyst, citric acid, 2, 3-dihydroquinazoline-4(1H)-ones, isatoic anhydride, multicomponent synthesis, primary amines.
Graphical Abstract
Current Organocatalysis
Title:Citric Acid: A Green Bioorganic Catalyst for One-Pot Three-Component Synthesis of 2,3-dihydroquinazoline-4 (1H)-ones
Volume: 3 Issue: 1
Author(s): Nafiseh Fahimi and Ali Reza Sardarian
Affiliation:
Keywords: Aldehydes, bioorganic catalyst, citric acid, 2, 3-dihydroquinazoline-4(1H)-ones, isatoic anhydride, multicomponent synthesis, primary amines.
Abstract: An efficient, mild, cost effective and eco-friendly synthesis of 2,3- dihydroquinazoline- 4(1H)-ones is described in which isatoic anhydride, primary amines and variety of aldehydes react in the presence of citric acid as a green, bioorganic and inexpensive catalyst via rapid one-pot threecomponent reaction in boiling ethanol.
Export Options
About this article
Cite this article as:
Fahimi Nafiseh and Reza Sardarian Ali, Citric Acid: A Green Bioorganic Catalyst for One-Pot Three-Component Synthesis of 2,3-dihydroquinazoline-4 (1H)-ones, Current Organocatalysis 2016; 3 (1) . https://dx.doi.org/10.2174/2213337202666150602221505
DOI https://dx.doi.org/10.2174/2213337202666150602221505 |
Print ISSN 2213-3372 |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-3380 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents An Improved Synthesis of m-Hydroxymexiletine, a Potent Mexiletine Metabolite
Drug Metabolism Letters Cardiac ATP-Sensitive Potassium Channels: A Potential Target for an Anti-Ischaemic Pharmacological Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Antithrombotic Therapy in Cardiac Embolism
Current Cardiology Reviews The Vernakalant Story: How Did It Come to Approval in Europe and What is the Delay in the U.S.A?
Current Cardiology Reviews Review of Treatment for Cocaine Dependence
Current Drug Abuse Reviews Editorial (Current Thought in Perinatal Haemodynamics)
Current Pediatric Reviews The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function
Medicinal Chemistry Reviews - Online (Discontinued) Role of Old Antibiotics in Multidrug Resistant Bacterial Infections
Current Drug Targets Kv1.5 Inhibitors for Treatment of Atrial Fibrillation: A Tradeoff between Selectivity and Non-selectivity
Current Topics in Medicinal Chemistry Cardio-Vascular Risks Associated with Clozapine Treatment
Current Psychiatry Reviews Biological Properties of Baicalein in Cardiovascular System
Current Drug Targets - Cardiovascular & Hematological Disorders The Neurokinins: Peptidomimetic Ligand Design and Therapeutic Applications
Current Medicinal Chemistry Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure- Activity Relationships of a Neuroprotective Peptide
Current Medicinal Chemistry Adrenal Insufficiency Caused by Locally Applied Glucocorticoids-Myth or Fact?
Current Medicinal Chemistry Vascular Endothelin and Hypertension - From Receptors to Medicine
Current Hypertension Reviews Opioids and Cannabinoids Interactions: Involvement in Pain Management
Current Drug Targets Polyglandular Autoimmune Syndromes
Current Immunology Reviews (Discontinued) Patient-Controlled Analgesia
Current Drug Targets New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs
Current Medicinal Chemistry